Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Dolby Laboratories (NYSE:DLB) reported fourth quarter and full year fiscal 2025 results on November 18, 2025. Q4 total revenue was $307M and GAAP net income was $49M ($0.51 diluted EPS); non-GAAP Q4 net income was $96M ($0.99 diluted EPS). For FY25, total revenue was $1.35B, GAAP net income was $255M ($2.62 diluted EPS) and non-GAAP net income was $414M ($4.24 diluted EPS). Cash flow from operations was $472M. Management announced a $0.36 per-share cash dividend payable Dec 10, 2025, repurchased ~$35M of stock in Q4 and has ~$277M remaining repurchase authorization. Dolby provided FY26 guidance with total revenue of $1.390B–$1.440B, and FY26 non-GAAP EPS of $4.19–$4.34.
Dolby Laboratories (NYSE:DLB) ha riportato i risultati del quarto trimestre e dell'intero anno fiscale 2025 il 18 novembre 2025. Ricavi totali Q4 sono stati $307M e l'utile netto GAAP è stato $49M (EPS diluito $0,51); l'utile netto Q4 non GAAP è stato $96M (EPS diluito $0,99). Per l'FY25, i ricavi totali sono stati $1,35B, l'utile netto GAAP è stato $255M (EPS diluito $2,62) e l'utile netto non GAAP è stato $414M (EPS diluito $4,24). Il flusso di cassa operativo è stato $472M. La direzione ha annunciato un dividendo in contanti di $0,36 per azione pagabile il 10 dicembre 2025, ha riacquistato circa $35M di azioni nel Q4 e ha una autorizzazione di riacquisto residua di circa $277M. Dolby ha fornito una guidance per FY26 con ricavi totali di $1,390B–$1,440B, e un EPS non GAAP per FY26 di $4,19–$4,34.
Dolby Laboratories (NYSE:DLB) informó los resultados del cuarto trimestre y del año fiscal 2025 el 18 de noviembre de 2025. Ingresos totales del Q4 fueron $307M y la utilidad neta GAAP fue $49M (EPS diluido $0,51); la utilidad neta no GAAP del Q4 fue $96M (EPS diluido $0,99). Para el FY25, los ingresos totales fueron $1,35B, la utilidad neta GAAP fue $255M (EPS diluido $2,62) y la utilidad neta no GAAP fue $414M (EPS diluido $4,24). El flujo de efectivo de operaciones fue $472M. La gerencia anunció un dividendo en efectivo de $0,36 por acción pagadero el 10 de diciembre de 2025, recompró ~$35M de acciones en el Q4 y tiene ~$277M de autorización de recompra restante. Dolby proporcionó una guía para FY26 con ingresos totales de $1,390M–$1,440M, y un EPS no GAAP para FY26 de $4,19–$4,34.
Dolby Laboratories (NYSE:DLB)는 2025년 11월 18일에 2025년 회계연도 4분기 및 전체 실적을 발표했다. Q4 총매출은 $307M이고 GAAP 순이익은 $49M (희석 EPS $0.51); 비GAAP Q4 순이익은 $96M (희석 EPS $0.99)였다. FY25의 경우, 총매출은 $1.35B, GAAP 순이익은 $255M (희석 EPS $2.62)이고 비GAAP 순이익은 $414M (희석 EPS $4.24)였다. 영업현금흐름은 $472M이었다. 경영진은 2025년 12월 10일 지급 예정의 주당 현금배당 $0.36를 발표했고, 4분기에 약 $35M의 주식 재매입을 했으며 남은 재매입 승인은 약 $277M이다. Dolby는 FY26 가이던스로 총매출 $1.390B–$1.440B, FY26 비GAAP EPS $4.19–$4.34를 제시했다.
Dolby Laboratories (NYSE:DLB) a publié les résultats du quatrième trimestre et de l’exercice fiscal 2025 le 18 novembre 2025. Chiffre d'affaires total T4 s’élevait à $307M et le résultat net GAAP était de $49M (EPS dilué $0,51) ; le résultat net non-GAAP du T4 était de $96M (EPS dilué $0,99). Pour l'exercice FY25, le chiffre d'affaires total était de $1,35B, le résultat net GAAP était de $255M (EPS dilué $2,62) et le résultat net non-GAAP était de $414M (EPS dilué $4,24). Le flux de trésorerie opérationnel était de $472M. La direction a annoncé un dividende en espèces de $0,36 par action payable le 10 décembre 2025, a racheté environ $35M d’actions au T4 et dispose d’une autorisation de rachat restante d’environ $277M. Dolby a donné des prévisions pour FY26 avec un chiffre d’affaires total de $1,390B–$1,440B, et un EPS non GAAP pour FY26 de $4,19–$4,34.
Dolby Laboratories (NYSE:DLB) meldete am 18. November 2025 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025. Q4-Umsatz betrug $307M und GAAP-Nettogewinn war $49M (verwässertes EPS $0,51); nicht-GAAP Q4 Nettogewinn betrug $96M (verwässertes EPS $0,99). Für das Geschäftsjahr FY25 lagen der Gesamtumsatz bei $1,35B, GAAP-Nettogewinn bei $255M (verwässertes EPS $2,62) und nicht-GAAP Nettogewinn bei $414M (verwässertes EPS $4,24). Der operative Cashflow betrug $472M. Das Management kündigte eine bar ausgeschüttete Dividende von $0,36 pro Aktie an, zahlbar am 10. Dezember 2025, repraesentierte ca. $35M an Aktien im Q4 und hat verbleibende Rückkauf-Berechtigung von ca. $277M. Dolby gab eine FY26-Prognose mit Gesamtumsatz von $1,390B–$1,440B und nicht-GAAP EPS für FY26 von $4,19–$4,34 bekannt.
Dolby Laboratories (NYSE:DLB) أبلغت عن نتائج الربع الرابع والسنة المالية 2025 في 18 نوفمبر 2025. إجمالي الإيرادات للربع الرابع كان $307M وصافي الربح وفق المعايير GAAP كان $49M (EPS مخفف 0.51$)؛ صافي الربح غير-GAAP للربع الرابع كان $96M (EPS مخفف 0.99$). بالنسبة للسنة المالية FY25، الإيرادات الإجمالية كانت $1.35B، صافي الربح وفق المعايير GAAP كان $255M (EPS مخفف 2.62$) وصافي الربح غير-GAAP كان $414M (EPS مخفف 4.24$). التدفقات النقدية من العمليات كانت $472M. أعلنت الإدارة عن توزيعات نقدية قدرها $0.36 للسهم الواحد قابلة للدفع في 10 ديسمبر 2025، وقد أعادت شراء أسهم بقيمة تقارب $35M في الربع الرابع ولديها تفويض لإعادة شراء بقيمة تقارب $277M متبقٍ. قدمت Dolby توجيهات FY26 بإيرادات إجمالية قدرها $1.390B–$1.440B، وربحية السهم غير GAAP FY26 قدرها $4.19–$4.34.
- Non-GAAP net income +12% to $414M for FY25
- Operating cash flow $472M (FY25 vs $327M prior year)
- Declared $0.36 per-share dividend payable Dec 10, 2025
- Repurchased $35M of shares in Q4; $277M repurchase authorization remaining
- FY26 guidance: $1.390B–$1.440B total revenue and non-GAAP EPS $4.19–$4.34
- GAAP net income declined to $255M in FY25 from $262M a year earlier
- Fourth-quarter GAAP EPS benefited from discrete tax items of per share
Insights
Solid revenue and cash flow growth, stronger non-GAAP earnings, capital returns, and FY26 guidance point to positive operational momentum.
Dolby Laboratories grew total revenue to
Risks and dependencies center on differences between GAAP and non-GAAP results and visibility limits in the outlook. GAAP net income declined slightly year-over-year to
Concrete items to watch: first quarter revenue guidance of
"We finished FY25 strong, growing Dolby Atmos, Dolby Vision and imaging patents, and expanding our addressable market with momentum in Dolby OptiView and the introduction of a new imaging patent pool for content streamers," said Kevin Yeaman, President and CEO, Dolby Laboratories. "As we head into FY26, I'm confident in our strategy to grow our business by delivering value across current and future ecosystems of creatives, content distributors and device makers."
Fourth Quarter Fiscal 2025 Financial Highlights
- Total revenue was
, compared to$307 million for the fourth quarter of fiscal 2024.$305 million - GAAP net income was
or$49 million per diluted share, compared to GAAP net income of$0.51 or$59 million per diluted share for the fourth quarter of fiscal 2024. On a non-GAAP basis, fourth quarter net income was$0.61 or$96 million per diluted share, compared to$0.99 or$78 million per diluted share for the fourth quarter of fiscal 2024. Fourth quarter net income included a benefit from discrete tax items of$0.81 per diluted share on a GAAP basis and$0.19 per diluted share on a non-GAAP basis.$0.28 - Dolby repurchased approximately 479,000 shares of its common stock for approximately
, and ended the quarter with approximately$35 million of stock repurchase authorization available going forward.$277 million
Full Year Fiscal 2025 Financial Highlights
- Total revenue was
, compared to$1.35 billion for the full year of fiscal 2024.$1.27 billion - GAAP net income was
, or$255 million per diluted share, compared to GAAP net income of$2.62 , or$262 million per diluted share, for the full year of fiscal 2024. On a non-GAAP basis, full year net income was$2.69 or$414 million per diluted share, compared to$4.24 or$369 million per diluted share for the full year of fiscal 2024.$3.79 - Cash flows from operations were
, compared to$472 million for the full year of fiscal 2024.$327 million
A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.
Recent Business Highlights
- Peacock started streaming its NFL Sunday Night Football games and NBA games in Dolby Atmos.
- In September we announced Dolby Vision 2, which expands the benefits of Dolby Vision beyond HDR, unlocking the full capabilities of modern displays and introducing new tools for artists.
- This quarter, TCL, Samsung, Hisense, Xiaomi, and Amazon launched TVs that feature Dolby Atmos and/or Dolby Vision.
- Instagram for iOS is now the first Meta app to support Dolby Vision.
- Douyin, known in many parts of the world as TikTok, made Dolby Vision available to its users in
China , giving them the ability to capture, share, and edit content in Dolby Vision. - This past quarter, we signed agreements with automakers Maruti Suzuki in
India , Deepal inChina , and VinFast inVietnam . - The first in-car game featuring Dolby Atmos, Loner, officially launched on Li Auto vehicles.
Upcoming Investor Event
Dolby is hosting an event at CES for the financial community where we will demonstrate a wide array of our technologies. The event will be held at 8:00 a.m. PT on Wednesday, January 7, 2026. Please send an email to IR@dolby.com for more information.
Dividend
Today, Dolby announced a cash dividend of
Financial Outlook
Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Annual Report on Form 10-K for fiscal 2025, to be filed on or around the date hereof.
Dolby is providing the following estimates for its first quarter of fiscal 2026:
- Total revenue is estimated to range from
to$315 million .$345 million - Licensing revenue is estimated to range from
to$290 million .$320 million - Gross margins are anticipated to be approximately
88% on a GAAP basis and approximately90% on a non-GAAP basis. - Operating expenses are anticipated to range from
to$235 million on a GAAP basis and from$245 million to$195 million on a non-GAAP basis.$205 million - Effective tax rate is anticipated to be around
23% on a GAAP basis and around21% on a non-GAAP basis. - Diluted earnings per share is anticipated to range from
to$0.39 on a GAAP basis and from$0.54 to$0.79 on a non-GAAP basis.$0.94
Dolby is providing the following estimates for the full year of fiscal 2026:
- Total revenue is expected to range from
to$1.39 0 billion .$1.44 0 billion - Licensing revenue is estimated to range from
to$1.28 5 billion .$1.33 5 billion - Gross margins are anticipated to be approximately
88% on a GAAP basis and approximately90% on a non-GAAP basis. - Operating expenses are anticipated to range from
to$930 million on a GAAP basis and from$950 million to$780 million on a non-GAAP basis.$800 million - Dolby expects operating margins to be roughly
21% on a GAAP basis and to be roughly34% on a non-GAAP basis. - Effective tax rate is anticipated to be around
23% on a GAAP basis and around21% on a non-GAAP basis. - Diluted earnings per share is anticipated to range from
to$2.61 on a GAAP basis and from$2.76 to$4.19 on a non-GAAP basis.$4.34
Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss fourth quarter and full year fiscal 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, November 18, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.
A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Tuesday, November 18, 2025, until 8:59 p.m. PT (11:59 p.m. ET) on Tuesday, November 25, 2025 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.
Non-GAAP Financial Information
To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:
Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.
Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.
Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.
Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.
Impact from Tax Reform: The enactment of the
Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including
as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.
Forward-Looking Statements
Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the first quarter of fiscal 2026 and full year fiscal 2026, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Annual Report on Form 10-K filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
About Dolby
Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.
Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in
|
DOLBY LABORATORIES, INC. C ONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts; unaudited) |
|||||
|
|
|||||
|
|
Fiscal Quarter Ended |
|
Fiscal Year Ended |
||
|
|
September 26,
|
September 27,
|
|
September 26,
|
September 27,
|
|
Revenue: |
|
|
|
|
|
|
Licensing |
$ 281,627 |
$ 282,705 |
|
$ 1,248,017 |
$ 1,181,794 |
|
Products and services |
25,397 |
22,101 |
|
101,113 |
91,927 |
|
Total revenue |
307,024 |
304,806 |
|
1,349,130 |
1,273,721 |
|
|
|
|
|
|
|
|
Cost of revenue: |
|
|
|
|
|
|
Cost of licensing |
21,111 |
18,764 |
|
83,619 |
67,204 |
|
Cost of products and services |
18,408 |
15,232 |
|
76,513 |
73,292 |
|
Total cost of revenue |
39,519 |
33,996 |
|
160,132 |
140,496 |
|
|
|
|
|
|
|
|
Gross profit |
267,505 |
270,810 |
|
1,188,998 |
1,133,225 |
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
Research and development |
67,465 |
68,636 |
|
261,792 |
263,663 |
|
Sales and marketing |
90,520 |
87,901 |
|
360,711 |
334,460 |
|
General and administrative |
73,715 |
69,209 |
|
286,529 |
270,392 |
|
Restructuring charges/(credits) |
6,128 |
(1,290) |
|
15,007 |
6,384 |
|
Total operating expenses |
237,828 |
224,456 |
|
924,039 |
874,899 |
|
|
|
|
|
|
|
|
Operating income |
29,677 |
46,354 |
|
264,959 |
258,326 |
|
|
|
|
|
|
|
|
Other income/(expense): |
|
|
|
|
|
|
Interest income/(expense), net |
5,060 |
6,854 |
|
15,376 |
34,077 |
|
Other income, net |
6,931 |
6,526 |
|
23,150 |
20,076 |
|
Total other income |
11,991 |
13,380 |
|
38,526 |
54,153 |
|
|
|
|
|
|
|
|
Income before income taxes |
41,668 |
59,734 |
|
303,485 |
312,479 |
|
Provision for/(benefit from) income taxes |
7,986 |
(868) |
|
(46,993) |
(48,163) |
|
Net income including noncontrolling interest |
49,654 |
58,866 |
|
256,492 |
264,316 |
|
Less: net income attributable to noncontrolling interest |
(322) |
(296) |
|
(1,474) |
(2,491) |
|
Net income attributable to Dolby Laboratories, Inc. |
$ 49,332 |
$ 58,570 |
|
$ 255,018 |
$ 261,825 |
|
|
|
|
|
|
|
|
Net income per share: |
|
|
|
|
|
|
Basic |
$ 0.52 |
$ 0.61 |
|
$ 2.66 |
$ 2.74 |
|
Diluted |
$ 0.51 |
$ 0.61 |
|
$ 2.62 |
$ 2.69 |
|
Weighted-average shares outstanding: |
|
|
|
|
|
|
Basic |
95,632 |
95,395 |
|
95,868 |
95,544 |
|
Diluted |
96,846 |
96,593 |
|
97,479 |
97,325 |
|
DOLBY LABORATORIES, INC. CONSOLIDATED BALANCE SHEETS (in thousands; unaudited) |
||
|
|
||
|
|
September 26,
|
September 27,
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ 701,893 |
$ 482,047 |
|
Restricted cash |
91,468 |
95,705 |
|
Short-term investments |
703 |
— |
|
Accounts receivable, net |
331,096 |
315,465 |
|
Contract assets, net |
180,804 |
197,478 |
|
Inventories, net |
30,424 |
33,728 |
|
Prepaid expenses and other current assets |
51,873 |
69,994 |
|
Total current assets |
1,388,261 |
1,194,417 |
|
Long-term investments |
80,205 |
89,267 |
|
Property, plant, and equipment, net |
470,608 |
479,109 |
|
Operating lease right-of-use assets |
33,204 |
39,046 |
|
Goodwill and intangible assets, net |
926,957 |
967,722 |
|
Deferred taxes |
214,361 |
219,758 |
|
Other non-current assets |
114,164 |
120,609 |
|
Total assets |
$ 3,227,760 |
$ 3,109,928 |
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ 17,840 |
$ 17,380 |
|
Accrued liabilities |
369,256 |
347,529 |
|
Income taxes payable |
8,928 |
9,045 |
|
Contract liabilities |
31,382 |
31,644 |
|
Operating lease liabilities |
10,384 |
12,238 |
|
Total current liabilities |
437,790 |
417,836 |
|
Non-current contract liabilities |
29,687 |
34,593 |
|
Non-current operating lease liabilities |
28,494 |
34,754 |
|
Other non-current liabilities |
99,843 |
135,852 |
|
Total liabilities |
595,814 |
623,035 |
|
|
|
|
|
Stockholders' equity: |
|
|
|
Class A common stock |
54 |
53 |
|
Class B common stock |
40 |
41 |
|
Retained earnings |
2,634,980 |
2,496,255 |
|
Accumulated other comprehensive loss |
(12,517) |
(19,187) |
|
Total stockholders' equity – Dolby Laboratories, Inc. |
2,622,557 |
2,477,162 |
|
Noncontrolling interest |
9,389 |
9,731 |
|
Total stockholders' equity |
2,631,946 |
2,486,893 |
|
Total liabilities and stockholders' equity |
$ 3,227,760 |
$ 3,109,928 |
|
DOLBY LABORATORIES, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands; unaudited) |
||
|
|
||
|
|
Fiscal Year Ended |
|
|
|
September 26,
|
September 27,
|
|
Operating activities: |
|
|
|
Net income including noncontrolling interest |
$ 256,492 |
$ 264,316 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
Depreciation and amortization |
87,827 |
75,559 |
|
Stock-based compensation |
128,514 |
119,825 |
|
Amortization of operating lease right-of-use assets |
10,770 |
11,768 |
|
Amortization of premium on investments |
— |
(2,919) |
|
Provision for/(benefit from) credit losses |
2,434 |
(2,256) |
|
Deferred income taxes |
4,988 |
(21,612) |
|
Share of net income of equity method investees, net of cash distributions |
(707) |
(2,023) |
|
Other non-cash items affecting net income |
(1,108) |
3,305 |
|
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable, net |
(18,463) |
(28,967) |
|
Contract assets, net |
16,680 |
(8,707) |
|
Inventories |
8,019 |
(2,654) |
|
Operating lease right-of-use assets |
(4,505) |
(8,420) |
|
Prepaid expenses and other assets |
15,223 |
(2,013) |
|
Accounts payable and accrued liabilities |
22,851 |
(34,554) |
|
Income taxes, net |
(42,829) |
(4,501) |
|
Contract liabilities |
(5,079) |
(9,738) |
|
Operating lease liabilities |
(8,503) |
(5,263) |
|
Other non-current liabilities |
(406) |
(13,894) |
|
Net cash provided by operating activities |
472,198 |
327,252 |
|
|
|
|
|
Investing activities: |
|
|
|
Purchases of marketable securities |
— |
(160,198) |
|
Proceeds from sales of marketable securities |
15,911 |
234,061 |
|
Proceeds from maturities of marketable securities |
— |
157,729 |
|
Proceeds from sale of assets held for sale |
16,881 |
— |
|
Purchases of property, plant, and equipment |
(36,348) |
(30,007) |
|
Business combinations, net of cash and restricted cash acquired, and other related payments |
(1,362) |
(487,877) |
|
Purchases of intangible assets |
(5,593) |
— |
|
Purchases of other investments |
(75) |
— |
|
Net cash used in investing activities |
(10,586) |
(286,292) |
|
|
|
|
|
Financing activities: |
|
|
|
Proceeds from issuance of common stock |
43,697 |
40,203 |
|
Repurchase of common stock |
(124,992) |
(160,001) |
|
Payment of excise tax on repurchase of common stock |
(261) |
— |
|
Payment of cash dividend |
(126,599) |
(114,579) |
|
Distributions to noncontrolling interest |
(1,847) |
(5,164) |
|
Purchase of noncontrolling interest in business combinations |
— |
(9,920) |
|
Shares repurchased for tax withholdings on vesting of restricted stock |
(37,236) |
(39,075) |
|
Equity issued in connection with business combination |
— |
722 |
|
Net cash used in financing activities |
(247,238) |
(287,814) |
|
|
|
|
|
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash |
1,235 |
6,640 |
|
Net increase/(decrease) in cash, cash equivalents, and restricted cash |
215,609 |
(240,214) |
|
Cash, cash equivalents, and restricted cash at beginning of period |
577,752 |
817,966 |
|
Cash, cash equivalents, and restricted cash at end of period |
$ 793,361 |
$ 577,752 |
|
Licensing Revenue by Market (unaudited) |
|||||||||||
|
|
|||||||||||
|
The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, |
|||||||||||
|
|
|||||||||||
|
|
Fiscal Quarter Ended |
|
Fiscal Year Ended |
||||||||
|
Market |
September 26, 2025 |
|
September 27, 2024 |
|
September 26, 2025 |
|
September 27, 2024 |
||||
|
Broadcast |
$ 107,174 |
38 % |
|
$ 95,779 |
34 % |
|
$ 428,471 |
34 % |
|
$ 409,105 |
35 % |
|
Mobile |
50,626 |
18 % |
|
48,701 |
17 % |
|
268,568 |
22 % |
|
235,774 |
20 % |
|
CE |
35,036 |
12 % |
|
42,024 |
15 % |
|
150,704 |
12 % |
|
165,817 |
14 % |
|
PC |
28,647 |
10 % |
|
34,077 |
12 % |
|
151,894 |
12 % |
|
141,300 |
12 % |
|
Other |
60,144 |
22 % |
|
62,124 |
22 % |
|
248,380 |
20 % |
|
229,798 |
19 % |
|
Total licensing revenue |
$ 281,627 |
100 % |
|
$ 282,705 |
100 % |
|
|
100 % |
|
|
100 % |
|
GAAP to Non-GAAP Reconciliations |
||||||
|
(unaudited) |
||||||
|
|
|
|
|
|
|
|
|
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the |
||||||
|
|
|
|
|
|
|
|
|
Net income: |
|
Fiscal Quarter Ended |
|
Fiscal Year Ended |
||
|
(in thousands) |
|
September 26,
|
September 27,
|
|
September 26,
|
September 27,
|
|
GAAP net income attributable to Dolby Laboratories, Inc. |
|
$ 49,332 |
$ 58,570 |
|
$ 255,018 |
$ 261,825 |
|
Stock-based compensation (1) |
|
31,052 |
29,679 |
|
128,514 |
119,825 |
|
Amortization of acquisition-related intangibles (2) |
|
10,115 |
6,296 |
|
40,856 |
15,552 |
|
Restructuring charges/(credits) |
|
6,128 |
(1,290) |
|
15,007 |
6,384 |
|
Impact of Tax Reform |
|
8,836 |
(10,042) |
|
8,836 |
(10,042) |
|
Income tax adjustments |
|
(9,211) |
(4,777) |
|
(34,720) |
(24,528) |
|
Non-GAAP net income attributable to Dolby Laboratories, Inc. |
|
$ 96,252 |
$ 78,436 |
|
$ 413,511 |
$ 369,016 |
|
|
|
|
|
|
|
|
|
(1) Stock-based compensation included in above line items: |
|
|
|
|
|
|
|
Cost of products and services |
|
$ 426 |
$ 362 |
|
$ 1,747 |
$ 1,501 |
|
Research and development |
|
9,284 |
9,703 |
|
38,500 |
38,214 |
|
Sales and marketing |
|
10,606 |
9,994 |
|
44,480 |
40,128 |
|
General and administrative |
|
10,736 |
9,620 |
|
43,787 |
39,982 |
|
|
|
|
|
|
|
|
|
(2) Amortization of acquisition-related intangibles included in above |
|
|
|
|
|
|
|
Cost of licensing |
|
$ 6,678 |
$ 2,789 |
|
$ 26,712 |
$ 2,890 |
|
Cost of products and services |
|
770 |
768 |
|
3,085 |
2,350 |
|
Sales and marketing |
|
354 |
867 |
|
1,765 |
2,824 |
|
General and administrative |
|
1,872 |
1,872 |
|
7,488 |
7,488 |
|
Other income, net |
|
441 |
— |
|
1,806 |
— |
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
Fiscal Quarter Ended |
|
Fiscal Year Ended |
||
|
|
|
September 26,
|
September 27,
|
|
September 26,
|
September 27,
|
|
GAAP diluted earnings per share |
|
$ 0.51 |
$ 0.61 |
|
$ 2.62 |
$ 2.69 |
|
Stock-based compensation |
|
0.32 |
0.30 |
|
1.32 |
1.23 |
|
Amortization of acquisition-related intangibles |
|
0.10 |
0.06 |
|
0.42 |
0.16 |
|
Restructuring charges/(credits) |
|
0.06 |
(0.01) |
|
0.15 |
0.07 |
|
Impact of Tax Reform |
|
0.09 |
(0.10) |
|
0.09 |
(0.11) |
|
Income tax adjustments |
|
(0.09) |
(0.05) |
|
(0.36) |
(0.25) |
|
Non-GAAP diluted earnings per share |
|
$ 0.99 |
$ 0.81 |
|
$ 4.24 |
$ 3.79 |
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding - diluted (in thousands) |
|
96,846 |
96,593 |
|
97,479 |
97,325 |
|
|
|
|
|
|
|
|
|
Impact of discrete tax items: |
|
|
|
|
Fiscal Quarter Ended |
|
|
|
|
|
|
|
September 26, 2025 |
|
|
Discrete tax items included in GAAP diluted earnings per share |
|
|
|
|
$ 0.19 |
|
|
Impact of Tax Reform |
|
|
|
|
0.09 |
|
|
Discrete tax items included in Non-GAAP diluted earnings per share |
|
|
|
|
$ 0.28 |
|
|
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the first quarter of fiscal 2026 and full year fiscal 2026 included in this release: |
||||||
|
|
|
|
|
|
|
|
|
Gross margin: |
|
|
Q1 2026 |
|
|
Fiscal 2026 |
|
GAAP gross margin |
|
|
88.0 % |
|
|
88.0 % |
|
Stock-based compensation |
|
|
0.1 % |
|
|
0.1 % |
|
Amortization of acquisition-related intangibles |
|
|
1.9 % |
|
|
1.9 % |
|
Non-GAAP gross margin |
|
|
90.0 % |
|
|
90.0 % |
|
|
|
|
|
|
|
|
|
Operating expenses (in millions): |
|
|
Q1 2026 |
|
|
Fiscal 2026 |
|
GAAP operating expenses (low - high end of range) |
|
|
|
|
|
|
|
Stock-based compensation |
|
|
(33) |
|
|
(130) |
|
Amortization of acquisition-related intangibles |
|
|
(2) |
|
|
(10) |
|
Restructuring charges |
|
|
(5) |
|
|
(10) |
|
Non-GAAP operating expenses (low - high end of range) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin: |
|
|
|
|
Fiscal 2026 |
|
|
GAAP operating margin |
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
9 % |
|
Amortization of acquisition-related intangibles |
|
|
|
|
|
3 % |
|
Restructuring charges |
|
|
|
|
|
1 % |
|
Non-GAAP operating margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate: |
|
|
Q1 2026 |
|
|
Fiscal 2026 |
|
GAAP effective tax rate |
|
|
23.0 % |
|
|
23.0 % |
|
Stock-based compensation (low - high end of range) |
|
|
( |
|
|
( |
|
Amortization of acquisition-related intangibles (low - high end of |
|
|
( |
|
|
( |
|
Non-GAAP effective tax rate |
|
|
21.0 % |
|
|
21.0 % |
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
Q1 2026 |
|
Fiscal 2026 |
||
|
|
|
Low |
High |
|
Low |
High |
|
GAAP diluted earnings per share (low - high end of range) |
|
$ 0.39 |
$ 0.54 |
|
$ 2.61 |
$ 2.76 |
|
Stock-based compensation |
|
0.34 |
0.34 |
|
1.36 |
1.36 |
|
Amortization of acquisition-related intangibles |
|
0.11 |
0.11 |
|
0.43 |
0.43 |
|
Restructuring charges |
|
0.05 |
0.05 |
|
0.10 |
0.10 |
|
Income tax adjustments |
|
(0.10) |
(0.10) |
|
(0.31) |
(0.31) |
|
Non-GAAP diluted earnings per share (low - high end of range) |
|
$ 0.79 |
$ 0.94 |
|
$ 4.19 |
$ 4.34 |
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding - diluted (in thousands) |
|
96,800 |
96,800 |
|
97,100 |
97,100 |
|
|
|
|
|
|
|
|
Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com
Media Contact:
media@dolby.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-fourth-quarter-and-fiscal-year-2025-financial-results-302619023.html
SOURCE Dolby Laboratories, Inc.